Publication | Open Access

Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment

Lipid DisorderCellular Cholesterol EffluxSimvastatin TreatmentCardiovascular DiseaseHypercholesterolaemic Type 1DiabetesPhysiologyPharmacologyHyperlipidemiaVascular BiologyMicrovascular DysfunctionMedicineDyslipidemia